Skip to main content

Main menu

  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE

User menu

  • Log out
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Neuroscience
  • Log out
  • Log in
  • My Cart
Journal of Neuroscience

Advanced Search

Submit a Manuscript
  • HOME
  • CONTENT
    • Early Release
    • Featured
    • Current Issue
    • Issue Archive
    • Collections
    • Podcast
  • ALERTS
  • FOR AUTHORS
    • Information for Authors
    • Fees
    • Journal Clubs
    • eLetters
    • Submit
  • EDITORIAL BOARD
  • ABOUT
    • Overview
    • Advertise
    • For the Media
    • Rights and Permissions
    • Privacy Policy
    • Feedback
  • SUBSCRIBE
PreviousNext
THIS WEEK IN THE JOURNAL

This Week in The Journal

Journal of Neuroscience 12 January 2005, 25 (2)
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Embedded ImageCellular/Molecular

Astrocytes Clock In

Laura M. Prolo, Joseph S. Takahashi, and Erik D. Herzog

(see pages 404-408)

Mammalian circadian rhythms are driven primarily by the suprachiasmatic nucleus (SCN) of the hypothalamus via a combination of diffusible factors and synaptic interactions. This clock function is usually considered to be the domain of SCN neurons with their circadian expression of genes. This week, Prolo et al. test whether glial cells can also act as circadian oscillators. They coupled the bioluminescent protein luciferase to clock genes, Period 1 in mice or Period 2 in rats. They then examined cultures of cortical astrocytes in the absence of neurons. The astrocytes expressed the circadian genes with a daily rhythm that waned after a week or so. However, the rhythm could be restored with treatments such as a change in media or entrained to cyclic changes in temperature. Glia cocultured with SCN neurons maintained their rhythmicity far longer than with cortical neurons, which the authors suggest may point to a diffusible factor from SCN neurons.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint

Period2::luciferase (Per2::luc) astrocytes in culture show circadian rhythms and a gradual decrease in bioluminescence during the 15 d after initial plating. See the article by Prolo et al. for details.

Embedded ImageDevelopment/Plasticity/Repair

Local Protein Synthesis and Regenerating Growth Cones

Poonam Verma, Sabrina Chierzi, Amanda M. Codd, Douglas S. Campbell, Ronald L. Meyer, Christine E. Holt, and James W. Fawcett

(see pages 331-342)

Axonal regeneration begins with a new growth cone emerging from a cut axonal tip. Inhibitory molecules in surrounding myelin and glia are thought to underlie the poor regenerative capacity of central axons, but differences in intrinsic neuronal capabilities may also contribute. This week, Verma et al. examine the importance of local protein synthesis and degradation in axonal regeneration. They severed axons of cultured retinal and dorsal root ganglion (DRG) neurons several hundred micrometers from the soma. As expected, the PNS neurons (DRGs) regenerated more successfully than did CNS (retinal) axons. The ability to regenerate correlated with axonal levels of translational and degradative machinery. Inhibitors of protein synthesis as well as inhibitors of proteasome-mediated degradation slowed or prevented axonal repair, even in axons that were completely isolated from their cell bodies. Inhibition of signaling pathways including target of rapamycin (TOR), p38 mitogen-activated protein kinase, and caspase-3 also reduced local protein synthesis.

Embedded ImageBehavioral/Systems/Cognitive

Differential Action of 5-HT on Frontal Lobe Functions

H. F. Clarke, S. C. Walker, H. S. Crofts, J. W. Dalley, T. W. Robbins, and A. C. Roberts

(see pages 532-538)

Inflexibility in responses to stimuli is characteristic of frontal lobe injury as well as schizophrenia and depression. Based on lesion studies, different regions of prefrontal cortex (PFC) have been implicated in such “executive” functions. For example, “reversal learning” tasks involve the orbitofrontal cortex, whereas “set-shifting” attentional tasks involve the lateral PFC. Ascending monoamine inputs are likely modulators of these functions. After serotonin (5-HT)-specific lesions of the orbitofrontal cortex, monkeys perseverate on a serial discrimination task (i.e., they continue to give a previously correct response). This week, Clarke et al. asked marmosets to turn their attention to a set-shifting task. Whereas in a serial discrimination reversal task monkeys are required to respond to a new stimulus, in set-shifting they must shift their attention to a different aspect of the stimulus. After 5,7-dihydroxytryptamine-induced depletion of serotonin in the PFC, the monkeys' ability to set-shift remained unimpaired. The results predict differential actions of serotonin modulation (e.g., by selective serotonin reuptake inhibitors) on frontal lobe functions.

Embedded ImageNeurobiology of Disease

Blocking Aβ-Stimulated Inflammation with Statins

Andrew Cordle and Gary Landreth

(see pages 299-307)

This week, Cordle and Landreth examine a novel action of statins beyond their well known ability to lower cholesterol. Statins work by inhibiting the rate-limiting enzyme 3-hydroxy-3-methylglutaryl-coenzyme A reductase in cholesterol synthesis. Population studies in humans also indicate that statins decrease the risk of Alzheimer's disease (AD), an effect that has been attributed to the sensitivity of amyloid precursor protein processing enzymes to membrane cholesterol content. However, the authors suggest that the effect of statins in AD may be anti-inflammatory rather than just lipid-lowering. In cultured THP-1 monocytes, β-amyloid (Aβ) stimulation produced less interleukin-1β, a marker of inflammation in the presence of statins, and Aβ-stimulated microglia produced fewer reactive oxygen species. These effects were independent of cholesterol levels. The authors conclude that depletion of lipid intermediates in cholesterol synthesis, particularly geranylgeranyl pyrophosphate, and downstream inhibition of isoprenylation form the link between statins and a reduction in microglial inflammatory responses in AD. Two actions for the price of one it seems.

Back to top

In this issue

The Journal of Neuroscience: 25 (2)
Journal of Neuroscience
Vol. 25, Issue 2
12 Jan 2005
  • Table of Contents
  • About the Cover
  • Index by author
Email

Thank you for sharing this Journal of Neuroscience article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
This Week in The Journal
(Your Name) has forwarded a page to you from Journal of Neuroscience
(Your Name) thought you would be interested in this article in Journal of Neuroscience.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
View Full Page PDF
Citation Tools
This Week in The Journal
Journal of Neuroscience 12 January 2005, 25 (2)

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Respond to this article
Request Permissions
Share
This Week in The Journal
Journal of Neuroscience 12 January 2005, 25 (2)
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Cellular/Molecular
    • Development/Plasticity/Repair
    • Behavioral/Systems/Cognitive
    • Neurobiology of Disease
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF

Responses to this article

Respond to this article

Jump to comment:

No eLetters have been published for this article.

Related Articles

Cited By...

More in this TOC Section

  • This Week in The Journal
  • This Week in The Journal
  • This Week in The Journal
Show more This Week in The Journal
  • Home
  • Alerts
  • Visit Society for Neuroscience on Facebook
  • Follow Society for Neuroscience on Twitter
  • Follow Society for Neuroscience on LinkedIn
  • Visit Society for Neuroscience on Youtube
  • Follow our RSS feeds

Content

  • Early Release
  • Current Issue
  • Issue Archive
  • Collections

Information

  • For Authors
  • For Advertisers
  • For the Media
  • For Subscribers

About

  • About the Journal
  • Editorial Board
  • Privacy Policy
  • Contact
(JNeurosci logo)
(SfN logo)

Copyright © 2023 by the Society for Neuroscience.
JNeurosci Online ISSN: 1529-2401

The ideas and opinions expressed in JNeurosci do not necessarily reflect those of SfN or the JNeurosci Editorial Board. Publication of an advertisement or other product mention in JNeurosci should not be construed as an endorsement of the manufacturer’s claims. SfN does not assume any responsibility for any injury and/or damage to persons or property arising from or related to any use of any material contained in JNeurosci.